Clinical

Dataset Information

Effects of neoadjuvant anti-angiogenic therapy on growth of colorectal cancer metastases


ABSTRACT: Primary objectives: To obtain proof of principle that outgrowth of metastatic disease in colorectal cancer, as observed after resection of the primary tumour, can be influenced by pre-operative treatment ( before resection of the primary tumour) with the anti-angiogenic agent bevacizumab Primary endpoints: A relative change in the SUV ( Standardized Uptake Value) of the liver metastases on PET-CT scan after 9 weeks

DISEASE(S): Liver Metastases,Synchronous Liver Metastases In Patients With The Primary Colorectal Tumour In Situ

PROVIDER: 2520748 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR